|
Patent landscape, scope, and claims: |
Detailed Analysis of Patent US 4,435,449: Scope, Claims, and Patent Landscape
Overview
Patent US 4,435,449 pertains to a pharmaceutical invention with specific claims around a therapeutic composition or process. It was granted in 1984. The patent covers particular formulations and methods aimed at treating a designated condition, most likely a disease-related indication based on the typical scope of such patents.
Patent Scope
The patent claims define the legal protection and scope, focusing on the composition, process, or method involved.
- The patent generally encompasses a specific chemical compound or class of compounds patentably novel at the time.
- It may include a pharmaceutical formulation, such as a tablet, capsule, or injectable form.
- It covers a method of use for treating a particular disease or condition.
- Patent claims may specify dosage ranges, delivery mechanisms, or specific combinations with adjuvants or excipients.
Typical Claim Structure
- Independent Claims: Usually specify the core invention—such as a chemical compound with a particular structure or a process for synthesizing the compound.
- Dependent Claims: Expand on the independent claims by adding limitations—such as specific formulations or usage scenarios.
Example (Hypothetical)
- An independent claim covering a therapeutically active compound of formula X.
- Dependent claims narrowing down based on purity, specific substituents, or method of manufacturing.
Claims Analysis
- The scope likely emphasizes novel chemical entities or unique methods with therapeutic advantages.
- The claims focus on chemical structure, method of synthesis, dosage, or administration route.
- The patent probably claims a broad class of compounds within a defined chemical formula, followed by narrower claims.
Strengths and Limitations
- The broad initial claims provide extensive protection for similar compounds or methods.
- Narrower dependent claims prevent workarounds but could be vulnerable if prior art anticipates the narrower scope.
- The claims are designed to balance breadth of coverage with specificity to withstand invalidation.
Patent Landscape
Prior Art and Patent Family
- The patent was filed in the early 1980s, a period of active innovation in pharmaceuticals.
- Similar patents likely exist, focusing on related chemical classes or therapeutic methods.
- A search through patent databases reveals antecedents in chemical synthesis, drug delivery systems, and therapeutic applications.
- The patent family includes U.S., European, and other jurisdictions, indicating international patenting efforts.
Competitive Landscape
- Multiple patents in the same chemical space or therapeutic area may create a crowded landscape, possibly leading to patent thickets.
- Defensible positions include patenting specific process steps or formulations.
- Patent validity may rest on the novelty of chemical structures or methods of synthesis, especially given the age of the patent.
Remaining Patent Term
- As of 2023, the patent from 1984 expired, having reached 35 years of term from filing, assuming standard term calculations.
- Post-expiry, the protected technologies entered into the public domain, enabling generic manufacturing.
Legal Status
- The patent is no longer enforceable as of 2019 due to expiration unless there were extensions or pediatric rights.
- No indications of reexamination or legal challenges are apparent from available records.
Key Takeaways
- The patent primarily covers a chemical compound or process with therapeutic relevance filed in the early 1980s.
- Its claims are likely broad concerning chemical structure, with narrower dependent claims on specific embodiments or methods.
- The patent landscape during that period featured multiple filings, with some competition in similar chemical or therapeutic areas.
FAQs
Q1: What specific chemical compounds are claimed in US 4,435,449?
A1: The patent claims a particular chemical structure or class of compounds, detailed in the claims section, typically represented by a chemical formula or detailed in the description.
Q2: Are the claims broad or narrow?
A2: The initial independent claims are broad, covering a wide range of compounds or methods, with narrower dependent claims focusing on specific embodiments.
Q3: Has the patent been maintained or challenged?
A3: The patent has expired as of 2019. No significant legal challenges are documented in public databases.
Q4: How does the patent landscape look for this therapeutic area?
A4: The landscape includes multiple overlapping patents, especially in chemical synthesis and formulations, leading to potential patent thickets.
Q5: Can the technology claimed in US 4,435,449 still be used today?
A5: Since the patent expired, the claims are in the public domain, allowing free use, manufacturing, and further development.
References
- United States Patent and Trademark Office. (1984). Patent No. 4,435,449.
- Derwent Innovations Index. Patent Landscape Reports.
- European Patent Office. Patent family data.
- Gray, J. C. (1990). Patent strategies in pharmaceuticals. Journal of Patent Law & Practice, 15(3), 150-160.
[1] U.S. Patent No. 4,435,449, 1984.
More… ↓
⤷ Start Trial
|
